market-trends is the sole category represented across all 1 tracked stories. Intrusion Shield is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Intrusion Inc.
market-trends is the sole category represented across all 1 tracked stories. Intrusion Shield is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention Intrusion Inc., all published on March 24, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Intrusion Inc.. Shared-story counts are live from our verified record — not editorial picks.
TELA Bio and Intrusion Inc. reported their Q4 and full-year 2025 financial results, highlighting growth in soft tissue reconstruction and advanced cybersecurity solutions. These reports, alongside a leadership transition at Reed's Inc., underscore the evolving landscape of medical technology and data protection in the healthcare sector.